Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
2.600
+0.040 (1.56%)
Aug 22, 2025, 4:00 PM - Market closed

Eledon Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
156246443163233
Upgrade
Market Cap Growth
59.63%465.07%38.87%-50.29%-72.98%3004.22%
Upgrade
Enterprise Value
49168-16-34-31284
Upgrade
Last Close Price
2.604.121.802.284.4115.40
Upgrade
PB Ratio
3.092.086.040.370.391.23
Upgrade
P/TBV Ratio
8.672.87-0.610.762.13
Upgrade
Debt / Equity Ratio
0.010.010.050.010.010.00
Upgrade
Quick Ratio
7.8912.1113.128.7119.2846.04
Upgrade
Current Ratio
8.1212.4214.419.1920.0746.57
Upgrade
Return on Equity (ROE)
30.03%-57.73%-255.03%-70.89%-19.46%-22.80%
Upgrade
Return on Assets (ROA)
-41.40%-33.11%-29.56%-18.88%-12.53%-7.98%
Upgrade
Return on Capital (ROIC)
-111.00%-69.64%-58.09%-19.91%-12.96%-8.28%
Upgrade
Earnings Yield
9.41%-14.70%-267.55%-280.45%-54.69%-9.77%
Upgrade
FCF Yield
-41.45%-19.21%-90.75%-90.62%-45.83%-6.52%
Upgrade
Buyback Yield / Dilution
-108.60%-97.18%-72.34%3.61%-921.03%-121.42%
Upgrade
Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q